T2 Biosystems (NASDAQ:TTOO) is scheduled to be releasing its earnings data before the market opens on Tuesday, November 12th. Analysts expect T2 Biosystems to post earnings of ($0.31) per share for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link.
Shares of TTOO opened at $2.66 on Friday. The stock has a market capitalization of $128.71 million, a PE ratio of -2.11 and a beta of 1.23. The company’s 50-day simple moving average is $2.58 and its 200-day simple moving average is $1.97. T2 Biosystems has a 1 year low of $0.52 and a 1 year high of $5.38.
A number of equities analysts have recently issued reports on TTOO shares. Svb Leerink raised their target price on shares of T2 Biosystems from $3.00 to $5.00 and gave the stock an “outperform” rating in a research report on Thursday, September 12th. Alliance Global Partners lowered shares of T2 Biosystems from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $5.00 to $0.40 in a research report on Thursday, August 1st. Leerink Swann set a $5.00 target price on shares of T2 Biosystems and gave the stock a “buy” rating in a research report on Thursday, September 12th. ValuEngine upgraded shares of T2 Biosystems from a “sell” rating to a “hold” rating in a research report on Thursday, August 1st. Finally, Janney Montgomery Scott upgraded shares of T2 Biosystems from a “neutral” rating to a “buy” rating and set a $6.00 target price on the stock in a research report on Thursday, September 12th. Six analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $5.18.
About T2 Biosystems
T2 Biosystems, Inc, an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. It provides T2 Magnetic Resonance platform that enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, and urine.
Featured Story: Understanding the different types of bonds
Receive News & Ratings for T2 Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T2 Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.